Roger Amerian
Pulmonary Disease · West Hills, CANPI 1033105614
Payments from drug & device makers
Across 168 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$586
- GSK$565
- Boehringer Ingelheim$509
- Grifols USA, LLC$234
- Actelion Pharmaceuticals US, Inc.$227
- EPI Health, LLC$178
- plus $356 from 7 others
What the payments were for
- Food & beverage$2,653100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $586 |
| GSK | 49 | $565 |
| Boehringer Ingelheim | 35 | $509 |
| Grifols USA, LLC | 18 | $234 |
| Actelion Pharmaceuticals US, Inc. | 12 | $227 |
| EPI Health, LLC | 1 | $178 |
| Advanced Respiratory, Inc | 6 | $136 |
| Sunovion Pharmaceuticals Inc. | 14 | $103 |
| AbbVie | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Sanofi | 1 | $24 |
| Electromed, Inc. | 1 | $16 |
| United Therapeutics Corporation | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sitavig$178
- Cloderm$178
- Minolira 105mg$178
- Minolira 135mg$178
- Rhofade$178
How this compares
$2,655 in reported general payments places this provider in the 55th percentile of 1,261 pulmonary disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in West Hills
- Toby MaherLos Angeles$27.6M
- David PhamWestminster$5.9M
- Andrew WachtelLos Angeles$5.9M
- Aaron WeinbergIrvine$5.1M
- Michael RothLos Angeles$4.5M
- Namita SoodSacramento$3.7M
- Edward FedermanSan Diego$3.6M
- Sanjay VadgamaSherman Oaks$3.3M
- Rajan SaggarLos Angeles$3.3M
- Samuel LouieSacramento$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.